Business

Successful completion of key studies in lead up to Phase I

Successful completion of key studies in lead up to Phase I

Neuroscientific Biopharmaceuticals Ltd.February 7, 20224
Successful completion of key studies in lead up to Phase I

About this update from Neuroscientific Biopharmaceuticals Ltd.

Neuroscientific Biopharmaceuticals Ltd has released a press release. View Attachment

View stock analysis, news, and events for Neuroscientific Biopharmaceuticals Ltd.

More from Neuroscientific Biopharmaceuticals Ltd.

All Neuroscientific Biopharmaceuticals Ltd. news →